ea0034p80 | Clinical practice/governance and case reports | SFEBES2014
Tan Hiang Leng
, Douek Isy
Introduction: The incidence of agranulocytosis with thionamide therapy is uncommon, ranging between 0.2 and 0.5 percent. Most reports document agranulocytosis after short duration of high dose Carbimazole in older patients. We report a 32-year-old lady with GravesÂ’ disease who developed neutropaenic sepsis secondary to Carbimazole therapy on 5 mg daily and on treatment for the last 13 months.Case report: Our patient was diagnosed with GravesÂ’s ...